N6-methyladenosine-modified circPLPP4 sustains cisplatin resistance in ovarian cancer cells via PIK3R1 upregulationHan Li, Weijing Zhang, Run Lin et al.|Molecular Cancer|2024Cited by 36
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trialGuoying Liu, Yan‐Qun Xiang, Wei‐Xiong Xia et al.|BMJ|2024Cited by 17